SC
GILD icon

Syon Capital’s Gilead Sciences GILD Stock Holding History

Syon Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89M Sell
20,745
-532
-3% -$74.5K 0.15% 99
2025
Q4 		$2.61M Buy
21,277
+1,008
+5% +$122K 0.13% 120
2025
Q3 		$2.25M Buy
20,269
+729
+4% +$82.9K 0.12% 118
2025
Q2 		$2.17M Buy
19,540
+903
+5% +$96.1K 0.14% 102
2025
Q1 		$2.09M Buy
18,637
+558
+3% +$57.6K 0.17% 91
2024
Q4 		$1.67M Buy
18,079
+3,678
+26% +$331K 0.15% 101
2024
Q3 		$1.21M Sell
14,401
-50
-0.3% -$3.81K 0.11% 143
2024
Q2 		$991K Buy
14,451
+606
+4% +$40.4K 0.09% 157
2024
Q1 		$1.01M Sell
13,845
-12,105
-47% -$931K 0.1% 153
2023
Q4 		$2.1M Buy
25,950
+13,504
+109% +$1.05M 0.09% 140
2023
Q3 		$933K Buy
+12,446
New +$957K 0.12% 114

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Syon Capital's GILD Position: Q1 2026 in Review

Syon Capital reduced its Gilead Sciences (GILD) stake by 2.5% in Q1 2026, selling an estimated $74.5K and leaving 20,745 shares worth $2.89M. The position accounts for 0.15% of the portfolio, ranked #99.

Syon Capital first reported a position in GILD in Q3 2023 and has held it in 11 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Syon Capital held 20,745 shares of Gilead Sciences worth $2.89M as of Q1 2026.
  • Syon Capital sold 532 Gilead Sciences shares in Q1 2026, an estimated $74.5K.
  • Gilead Sciences made up 0.15% of Syon Capital's portfolio in Q1 2026, its #99 holding.
  • Syon Capital first reported a position in Gilead Sciences in Q3 2023 and has held it in 11 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.